文献速递肾移植

标准或扩大标准供肾移植能否改善患者生存?比利时队列研究结果

Does kidney transplantation with a standard or expanded criteria donor improve patient survival? Results from a Belgian cohort.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该研究分析2000至2012年比利时3808例等待首次 deceased donor 肾移植的成人患者,比较标准供肾(SCD)与扩大标准供肾(ECD)移植相较于透析的生存获益。结果显示,≥65岁患者中仅SCD移植较透析有显著生存获益,ECD移植获益可能很小。

要点

  • ≥65岁患者中,SCD移植较透析显著降低死亡率。
  • ECD移植在≥65岁患者中生存获益可能很小。
  • 移植后最初数月死亡风险高于透析,SCD比ECD更早达到等效风险。

核心结论

  • 老年患者接受SCD移植较透析可能获得生存获益,而ECD移植较透析的生存获益可能很小。

研究设计与样本

  • 分析2000至2012年比利时3808例等待首次 deceased donor 肾移植的成人患者,随访至中位等待时间加移植后3年。

主要发现

  • ≥65岁患者中,SCD移植死亡率为16.3%(95%CI 13.2-19.9),ECD移植为20.5%(95%CI 16.1-24.6),持续透析为24.6%(95%CI 19.4-29.5)。
  • 移植后最初数月相对死亡风险高于透析,SCD移植比ECD移植更早达到与透析等效的风险水平(所有年龄组)。

临床怎么用

  • 对≥65岁等待肾移植患者,优先考虑SCD移植可能带来生存获益,ECD移植需权衡其微小获益。

局限性

  • 原文未明确报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Changes in recipient and donor factors have reopened the question of survival benefits of kidney transplantation versus dialysis. METHODS: We analysed survival among 3808 adult Belgian patients waitlisted for a first deceased donor kidney transplant from 2000 to 2012. The primary outcome was mortality during the median waiting time plus 3 years of follow-up after transplantation or with continued dialysis. Outcomes were analysed separately for standard criteria donor (SCD) and expanded criteria donor (ECD) kidney transplants. We adjusted survival analyses for recipient age (20-44, 45-64 and ≥65 years), sex and diabetes as the primary renal disease. RESULTS: Among patients ≥65 years of age, only SCD transplantation provided a significant survival benefit compared with dialysis, with a mortality of 16.3% [95% confidence interval (CI) 13.2-19.9] with SCD transplantation, 20.5% (95% CI 16.1-24.6) with ECD transplantation and 24.6% (95% CI 19.4-29.5) with continued dialysis. Relative mortality risk was increased in the first months after transplantation compared with dialysis, with equivalent risk levels reached earlier with SCD than ECD transplantation in all age groups. CONCLUSIONS: The results of this study suggest that older patients might gain a survival benefit with SCD transplantation versus dialysis, but any survival benefit with ECD transplantation versus dialysis may be small.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Hellemans R, Kramer A, De Meester J, et al. Does kidney transplantation with a standard or expanded criteria donor improve patient survival? Results from a Belgian cohort. Nephrol Dial Transplant. 2021. PMID: 33650633. doi:10.1093/ndt/gfab024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。